comparemela.com

Page 6 - Eur Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trial of Ferric Carboxymaltose in Heart Failure Does Not Meet Primary Endpoint

HEART-FID trial presented in a Hot Line session Saturday at ESC Congress 2023

Noord hollandRobert mentzYork heart associationDuke clinical research instituteDrug administrationHot lineNew york heart associationEur heartCirc heart

Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction

Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenNikolaos dagresGerhard hindricksJose luis merinoHeart center leipzigSteering committeeEuropean society of cardiologyEuropean heart rhythm associationGerman heart center charitEuropean societyProfessor gerhard hindricksProfessor jose luis merinoEur heartEurj heart

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMasahiro natsuakiAcademic research consortiumSaga universityHot lineBleeding academic research consortiumEur heart

Role of Intravenous Iron in Spotlight At ESC Congress 2023

The largest trial to date, a meta-analysis, and new guideline recommendations have placed a spotlight on the role and benefit of iron supplementation in patients with heart failure and iron deficiency at ESC Congress 2023.

Noord hollandRobert mentzPiotr ponikowskiWroclaw medical university piotr ponikowskiInstitute of heart diseasesWroclaw medical universityCongress homeEuropean society of cardiologyEuropean societyDuke university schoolWin ratioHazard ratioHeart failure sectionHeart diseasesRate ratioIron supplementation recommendations

IV Iron Shows Only Modest Benefit in HF: HEART-FID

The largest ever study of IV iron supplementation in patients with heart failure failed to meet a new rigorous definition of significance, and the results were generally regarded as disappointing.

Duke universityNorth carolinaUnited statesNoord hollandUnited kingdomRegion flamandeVifor pharmaJohn mcmurrayWilfried mullensPiotr ponikowskiPieter martensScott solomonRobertj mentzBoehringer ingelheimDrug administrationRadcliffe group

vimarsana © 2020. All Rights Reserved.